DavidAndrewTompkinsMDMHS(He/Him)

PubMed

• 1 citations
  Assessing the Acceptability of Yoga Among Patients with and without Chronic Pain Enrolled in a Licensed Opioid Treatment Program.
  Elnaz Ahmadi, Charlotte Evans, Gabrielle Agin-Liebes, David Andrew Tompkins> ;International Journal of Yoga Therapy. 2022 Jan 1
• 9 citations
  "I got a bunch of weed to help me through the withdrawals": Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums.
  Meredith C Meacham, Alicia L Nobles, D Andrew Tompkins, Johannes Thrul> ;Plos One. 2022 Jan 1
• National trends in testing for hepatitis C virus in licensed opioid treatment programs: Differences by facility ownership and state medicaid expansion status
  George Pro, D. Andrew Tompkins, Soraya Azari, Nickolas Zaller> ;Drug and Alcohol Dependence. 2021 Nov 1
• 2 citations
  Methadone maintenance patients lack analgesic response to a cumulative intravenous dose of 32 mg of hydromorphone.
  Gabrielle Agin-Liebes, Andrew S. Huhn, Eric C. Strain, George E. Bigelow, Michael T. Smith, Robert R. Edwards, Valerie A. Gruber, D. Andrew Tompkins> ;Drug and Alcohol Dependence. 2021 Sep 1
• 17 citations
  Experimental sleep disruption attenuates morphine analgesia: findings from a randomized trial and implications for the opioid abuse epidemic.
  Michael T. Smith, Chung Jung Mun, Bethany Remeniuk, Patrick H. Finan, Claudia M. Campbell, Luis F. Buenaver, Mercedes Robinson, Brook Fulton, David A. Tompkins, Jean M...> ;Scientific Reports. 2020 Nov 18
• 29 citations
  Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes
  Kelly E. Dunn, Elise M. Weerts, Andrew S. Huhn, Jennifer R. Schroeder, D. Tompkins, George E. Bigelow, Eric C. Strain> ;Addiction Biology. 2020 Jan 1
• 5 citations
  The relationship between pupil diameter and other measures of opioid withdrawal during naloxone precipitated withdrawal.
  Cecilia L. Bergeria, Andrew S. Huhn, D. Andrew Tompkins, George E. Bigelow, Eric C. Strain, Kelly E. Dunn> ;Drug and Alcohol Dependence. 2019 Sep 1
• 10 citations
  Recovery Goals and Long-term Treatment Preference in Persons Who Engage in Nonmedical Opioid Use.
  Kaitlyn R. Hay, Andrew S. Huhn, D. Tompkins, Kelly E. Dunn> ;Journal of Addiction Medicine. 2019 Jul 1
• 15 citations
  Risk assessments for quality-assured, source-segregated composts and anaerobic digestates for a circular bioeconomy in the UK
  Philip J. Longhurst, David A. Tompkins, Simon J. T. Pollard, Rupert Hough, B. J. Chambers, Paul Gale, Sean Tyrrel, Raffaella Villa, M. Taylor, Shaomin Wu, Ruben Sakrab...> ;Environment International. 2019 Mar 28
• 13 citations
  Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals.
  Andrew S. Huhn, Eric C. Strain, George E. Bigelow, Michael T. Smith, Robert R. Edwards, D. Andrew Tompkins> ;Anesthesiology. 2019 Jan 1
• Extended-release injectable naltrexone (XR-NTX): a response to clinical issues raised by Brewer & Streel.
  Brantley P. Jarvis, August F. Holtyn, Shrinidhi Subramaniam, D. Andrew Tompkins, Emmanuel A. Oga, George E. Bigelow, Kenneth Silverman> ;Addiction. 2019 Jan 1
• 17 citations
  Individuals with Chronic Pain Who Misuse Prescription Opioids Report Sex-Based Differences in Pain and Opioid Withdrawal.
  Andrew S. Huhn, D. Andrew Tompkins, Claudia M. Campbell, Kelly E. Dunn> ;Pain Medicine. 2019 Oct 1
• 57 citations
  Sex differences in measures of central sensitization and pain sensitivity to experimental sleep disruption: implications for sex differences in chronic pain.
  Michael T. Smith, Bethany Remeniuk, Patrick H. Finan, Traci J. Speed, D. Andrew Tompkins, Mercedes Robinson, Kaylin Gonzalez, Martin F. Bjurström, Michael R. Irwin> ;Sleep. 2019 Feb 1
• 61 citations
  A hidden aspect of the U.S. opioid crisis: Rise in first-time treatment admissions for older adults with opioid use disorder.
  Andrew S. Huhn, Eric C. Strain, D. Andrew Tompkins, Kelly E. Dunn> ;Drug and Alcohol Dependence. 2018 Dec 1
• 24 citations
  Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients
  Andrew S. Huhn, Mary M. Sweeney, Robert K. Brooner, Michael Kidorf, D. Andrew Tompkins, Hasan Ayaz, Kelly E. Dunn> ;Neuropsychopharmacology. 2019 Mar 1
• Psychiatric Disorders and Comorbid Cannabis Use: When Should We Be Concerned and What Can We Do About It?
  Derek D. Satre, Brian Borsari, D. Andrew Tompkins, Danielle E. Ramo> ;The Journal of Clinical Psychiatry. 2018 Sep 11
• 30 citations
  Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial
  Adam Bisaga, Paolo Mannelli, Miao Yu, Narinder Nangia, Christine Graham, D. Andrew Tompkins, Thomas R. Kosten, Sarah C. Akerman, Bernard L. Silverman, Maria A. Sullivan> ;Drug and Alcohol Dependence. 2018 Jun 1
• 124 citations
  Extended-release injectable naltrexone for opioid use disorder: a systematic review.
  Brantley P. Jarvis, August F. Holtyn, Shrinidhi Subramaniam, D. Andrew Tompkins, Emmanuel A. Oga, George E. Bigelow, Kenneth Silverman> ;Addiction. 2018 Jul 1
• 37 citations
  Frequency and correlates of sleep disturbance in methadone and buprenorphine-maintained patients
  Kelly E. Dunn, Patrick H. Finan, D. Andrew Tompkins, Eric C. Strain> ;Addictive Behaviors. 2018 Jan 1
• 9 citations
  To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self‐identified ...
  D. Andrew Tompkins, Andrew S. Huhn, Patrick S. Johnson, Michael T. Smith, Eric C. Strain, Robert R. Edwards, Matthew W. Johnson> ;Addiction. 2018 Jan 1
• Tramadol Extended-Release and Opioid Withdrawal Management-Legal Implications-Reply.
  Kelly E. Dunn, D. Andrew Tompkins, Eric C. Strain> ;JAMA Psychiatry. 2017 Dec 27
• 31 citations
  The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use.
  Andrew S. Huhn, D. Andrew Tompkins, Kelly E. Dunn> ;Drug and Alcohol Dependence. 2017 Nov 1
• 30 citations
  Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
  Kelly E. Dunn, D. Andrew Tompkins, George E. Bigelow, Eric C. Strain> ;JAMA Psychiatry. 2017 Sep 1
• 154 citations
  Providing chronic pain management in the "Fifth Vital Sign" Era: Historical and treatment perspectives on a modern-day medical dilemma
  D. Andrew Tompkins, J. Greg Hobelmann, Peggy Compton> ;Drug and Alcohol Dependence. 2017 Apr 1
• 2 citations
  Pain catastrophizing may moderate the association between pain and secondary hyperalgesia.
  Alexander J. Pressman, B. Lee Peterlin, David A. Tompkins, Rachel E. Salas, Luis F. Buenaver, Jennifer A. Haythornthwaite, Claudia M. Campbell> ;Journal of Applied Biobehavioral Research. 2017 Mar 1
• Join now to see all

Journal Articles

• Prefrontal Cortex Response to Drug Cues, Craving, and Current Depressive Symptoms Are Associated with Treatment Outcomes in Methadone-Maintained Patients  
  Michael S Kidorf, D Andrew Tompkins, Nature
• Sex Differences in Measures of Central Sensitization and Pain Sensitivity to Experimental Sleep Disruption: Implications for Sex Differences in Chronic Pain  
  Traci J Speed, D Andrew Tompkins, Patrick H Finan, Sleep
• Sleep duration mediates the relationship between ethnic differences and experimental pain perception  
  McCauley L, Bond K, Bounds S, Tripp M, Buenaver L, Tompkins D, Smith M, Haythornthwaite J, Campbell C, J Pain, 4/1/2013
• Experimental pain sensitivity in opioid dependent patients: a preliminary examination of opioid-induced hyperalgesia  
  Bounds S, Campbell C, Edwards R, Smith M, Strain E, Tompkins D, J Pain, 4/1/2013
• A prospective study of withdrawal-associated hyperalgesia in opioid dependent volunteers  
  Tompkins D, Smith M, Campbell C, Strain E, J Pain, 4/1/2013
• "A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended release in very heavy drinkers"  
  Fertig JB, Ryan ML, Falk DE, Litten RZ, Mattson ME, Ransom J, Rickman WJ, Scott C, Ciraulo D, Green AI, Ait-Daoud Tiouririne N, Johnson B, Pettinati H, Strain EC, Devi..., Alcoholism: Clin Exp Rsch, 8/1/2012
• "Treatment of gender identity disorder"  
  Byne W, Bradley SJ, Coleman E, Eyler AE, Green R, Menvielle E, Meyer-Bahlburg HF, Pleak RR, Tompkins DA, Am J Psychiatry, 8/1/2012
• "Ethnic differences in capsaicin pain response in human subjects"  
  Tripp M, McCauley L, Bond K, Simango M, Tompkins D, Edwards R, Haythornthwaite J, Campbell C, J Pain, 4/1/2012
• "Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone"  
  Tompkins DA, Lanier RK, Harrison JA, Strain EC, Bigelow GE, Psychopharm, 7/1/2010
• "A prospective study of opioid induced hyperalgesia in healthy volunteers"  
  Tompkins D, Smith M, Bigelow G, Strain E, J Pain, 4/1/2010
• "Concurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdraw...  
  Tompkins DA, Bigelow GE, Harrison JA, Johnson RE, Fudala PJ, Strain EC, Drug Alc Dep, 11/1/2009
• "Hematological adverse events in clozapine-treated children and adolescents"  
  Gerbino-Rosen G, Roofeh D, Tompkins DA, Feryo D, Nusser L, Kranzler H, Napolitano B, Frederickson A, Henderson I, Rhinewine J, Kumra S, J Am Acad Child Adolesc Psychiatry, 10/1/2005
• Neutropenia and agranulocytosis in treatment-refractory adolescents receiving clozapine  
  Kranzler HN, Gerbino-Rosen G, Tompkins DA, Feryo D, Nussbaum L, Roofeh D, Fisch G, Frederickson A, Napolitano B, Kumra S, Schiz Bull, 4/1/2005
• "Phenotypic screening of mutations in Pmr1, the yeast secretory pathway Ca2+/Mn2+-TPase, reveals residues critical for ion selectivity and transport"  
  Wei Y, Chen J, Rosas G, Tompkins DA, Holt PA, Rao R, J Biol Chem, 8/1/2000
• Join now to see all